Literature DB >> 15987932

Gestational exposure to lovastatin followed by cardiac malformation misclassified as holoprosencephaly.

Robin J Edison, Maximilian Muenke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15987932     DOI： 10.1056/NEJM200506303522622

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 2.  Statins and pregnancy: between supposed risks and theoretical benefits.

Authors:  Edouard Lecarpentier; Olivier Morel; Thierry Fournier; Elisabeth Elefant; Pascale Chavatte-Palmer; Vassilis Tsatsaris
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

3.  Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function.

Authors:  F Lacbawan; B D Solomon; E Roessler; K El-Jaick; S Domené; J I Vélez; N Zhou; D Hadley; J Z Balog; R Long; A Fryer; W Smith; S Omar; S D McLean; K Clarkson; A Lichty; N J Clegg; M R Delgado; E Levey; E Stashinko; L Potocki; M I Vanallen; J Clayton-Smith; D Donnai; D W Bianchi; P B Juliusson; P R Njølstad; H G Brunner; J C Carey; U Hehr; J Müsebeck; P F Wieacker; A Postra; R C M Hennekam; M-J H van den Boogaard; A van Haeringen; A Paulussen; J Herbergs; C T R M Schrander-Stumpel; A R Janecke; D Chitayat; J Hahn; D M McDonald-McGinn; E H Zackai; W B Dobyns; M Muenke
Journal:  J Med Genet       Date:  2009-04-02       Impact factor: 6.318

Review 4.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

5.  Heterotrimeric G proteins regulate a noncanonical function of septate junction proteins to maintain cardiac integrity in Drosophila.

Authors:  Peng Yi; Aaron N Johnson; Zhe Han; Jiang Wu; Eric N Olson
Journal:  Dev Cell       Date:  2008-11       Impact factor: 12.270

6.  Statins and congenital malformations: cohort study.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; Michael A Fischer; Ellen W Seely; Jeffrey L Ecker; Jessica M Franklin; Rishi J Desai; Cora Allen-Coleman; Helen Mogun; Jerry Avorn; Krista F Huybrechts
Journal:  BMJ       Date:  2015-03-17

7.  Holoprosencephaly.

Authors:  Ameer Hamza; Martha Jaye Higgins
Journal:  Autops Case Rep       Date:  2017-12-08

Review 8.  Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.

Authors:  M R Boland; N P Tatonetti
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

Review 9.  Alobar holoprosencephaly associated with a rare chromosomal abnormality: Case report and literature review.

Authors:  Crîngu Antoniu Ionescu; Dan Calin; Dan Navolan; Alexandra Matei; Mihai Dimitriu; Catalin Herghelegiu; Liana Ples
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

10.  Risk of congenital anomalies in pregnant users of statin drugs.

Authors:  Benjamin Ofori; Evelyne Rey; Anick Bérard
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.